Abstract:Utilisation of RNA-binding proteins (RBPs) is an important aspect of post-transcriptional regulation of viral RNA. Viruses such as influenza A viruses (IAV) interact with RBPs to regulate processes including splicing, nuclear export and trafficking, while also encoding RBPs within their genomes, such as NP and NS1. But with almost 1000 RBPs encoded within the human genome it is still unclear what role, if any, many of these proteins play during viral replication. Using the RNA interactome capture (RIC) technique, we isolated RBPs from IAV infected cells to unravel the RBPome of mRNAs from IAV infected human cells. This led to the identification of one particular RBP, MKRN2, that associates with and positively regulates IAV mRNA. Through further validation, we determined that MKRN2 is involved in the nuclear-cytoplasmic trafficking of IAV mRNA potentially through an association with the RNA export mediator GLE1. In the absence of MKRN2, IAV mRNAs accumulate in the nucleus of infected cells, which may lead to their degradation by the nuclear RNA exosome complex. MKRN2, therefore, appears to be required for the efficient nuclear export of IAV mRNAs in human cells. During the course of an influenza A virus infection various cellular proteins and systems must be hijacked for the virus to successfully replicate and spread to neighbouring cells. This includes cellular translation machinery, splicing components, and systems for RNA trafficking. Herein, we sought to uncover a subset of RNA-binding proteins utilised by IAV mRNA in the hopes that, by revealing an essential part in the viral life cycle future therapeutics could be targeted to prevent this step happening and thus block virus spread. Through our methods of molecular virology and mass spectrometry we uncovered the cellular protein MKRN2, previously not implicated in any stages of the viral life cycle. We found that MKRN2 binds to IAV mRNAs and is involved in the trafficking of these viral mRNAs out of the nucleus and into the cytoplasm, where they can then be translated into viral proteins. By blocking MKRN2 we could significantly inhibit normal viral replication. We speculate that by preventing these viral mRNAs from being efficiently trafficked out of the nucleus, they are more likely to be degraded by RNA exonucleases found within the nucleus.

Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication

The Interferon-Induced Protein with Tetratricopeptide Repeats Repress Influenza Virus Infection by Inhibiting Viral RNA Synthesis

Zinc-finger CCHC-type containing protein 8 promotes RNA virus replication by suppressing the type-I interferon responses

Nuclear RNAi Modulates Influenza A Virus Infectivity By Downregulating Type-I Interferon Response

LncNSPL facilitates influenza A viral immune escape by restricting TRIM25-mediated K63-linked RIG-I ubiquitination

p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling

Identification of an Interferon-Stimulated Long Noncoding RNA (LncRNA ISR) Involved in Regulation of Influenza A Virus Replication

Influenza Virus Exploits an Interferon-Independent lncRNA to Preserve Viral RNA Synthesis through Stabilizing Viral RNA Polymerase PB1.

Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity

The IFN‐inducible GTPase IRGB10 Regulates Viral Replication and Inflammasome Activation During Influenza A Virus Infection in Mice

Novel CRITR-seq approach reveals influenza transcription is modulated by NELF and is a key event precipitating an interferon response

Lnc-RPS6P3 Inhibits Influenza A Virus Replication and Attenuates the Inhibitory Effect of NS1 on Innate Immune Response

Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.

Identifying cellular RNA-binding proteins during infection uncovers a role for MKRN2 in influenza mRNA trafficking

Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication

LncRNA LINC02574 Inhibits Influenza A Virus Replication by Positively Regulating the Innate Immune Response

CRISPR editing of candidate host factors that impact influenza A virus infection

The NS1 protein of influenza B virus binds 5’-triphosphorylated dsRNA to suppress RIG-I activation and the host antiviral response

Influenza A virus inhibits TET2 expression by endoribonuclease PA-X to attenuate type I interferon signaling and promote viral replication

A novel lncRNA DFRV plays a dual function in influenza A virus infection

RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling